<DOC>
	<DOC>NCT02854449</DOC>
	<brief_summary>This study will follow-up different immune cell populations in the blood before, during and after high dose radiation therapy which should give new information of the efficacy of Local Hypofractionated Radiotherapy and a rationale for adjuvant immunotherapy.</brief_summary>
	<brief_title>Tumor Response in Hypofractionated Radiotherapy</brief_title>
	<detailed_description>- Patient information and collection of a signed informed consent form - Clinical data collection - Blood samples of 5 mL: 1. after registration, prior to the first fraction of radiotherapy 2. during radiotherapy sessions 3. one month, 3 months after the last radiotherapy session - Storage of the blood samples at ambient temperature - Transportation of the samples to the Institute of Biology of Lille (IBL) - CNRS UMR8161 for analysis - Destruction of the samples at the end of the analysis</detailed_description>
	<criteria>Patient requiring a hypofractionated irradiation; pathologically confirmed Unspecified Adult Solid Tumor Age ≥ 18 years old KPS≥70 Signed written informed consent. Patient treated by chemotherapy, targeted or immunotherapy within 21 days before the first sampling, Pregnant or breastfeeding woman, Patient under guardianship or tutorship.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Immune Marker</keyword>
	<keyword>Immunologic Marker</keyword>
	<keyword>Radiotherapy</keyword>
	<keyword>Dose Hypofractionation</keyword>
</DOC>